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Objective: To determine whether there are differences in quality of life (QoL) improvement after
treatment with the trial-based thought record (TBTR) versus conventional cognitive therapy (CCT) in
patients with social anxiety disorder (SAD).
Method: A randomized trial comparing TBTR with a set of CCT techniques, which included the
standard 7-column dysfunctional thought record (DTR) and the positive data log (PDL) in patients with
SAD, generalized type.
Results: Repeated measures analysis of variance (ANOVA) revealed a significant time effect in the
general health, vitality, social functioning, and mental health domains of the Short Form 36. It also
indicated significant treatment effects on the bodily pain, social functioning, role-emotional, and
mental health domains, with higher scores in the TBTR group. One-way analysis of covariance
(ANCOVA), using pretreatment values as covariates, showed that TBTR was associated with
significantly better QoL post-treatment (bodily pain, social functioning and role-emotional) and at
follow-up (role-emotional). A significant treatment effect on the role-emotional domain at 12-month
follow-up denoted a sustained effect of TBTR relative to CCT.
Conclusion: This study provided preliminary evidence that TBTR is at least as effective as CCT in
improving several domains of QoL in SAD, specifically when the standard 7-column DTR and the PDL
are used.
Keywords: Cognitive therapy; randomized trial; social anxiety disorder; social phobia; quality of
life; trial-based cognitive therapy; trial-based thought record
Introduction
Social anxiety disorder (SAD), also called social phobia,
is a chronic and disabling condition. It is assumed to be
the most common anxiety disorder, with a lifetime
prevalence of 12%,1 and a 12-month prevalence of 7%.
A total of 70% of cases are categorized as severe or
moderate.2 Cognitive behavioral therapy (CBT) has been
shown to be effective in SAD,3 but 40 to 50% of patients
show little or no improvement after treatment.4 Although
CBT has recently been refined to target more specific
cognitive processes believed to maintain and exacerbate
symptomatology,5,6 leading to greater reductions in self-
reported social anxiety symptoms than earlier protocols,
newer cognitive behavioral strategies are still needed to
maximize treatment efficacy.7
Quality of life (QoL) is highly compromised in SAD.8-10
In a sample of predominantly untreated patients with SAD
symptoms recruited over two decades, QoL was sig-
nificantly reduced in both pure and comorbid SAD,
especially in scales measuring general health, role-
limitations due to emotional health, social functioning,
general mental health, and vitality. Together, at least 50%
of all patients suffering from moderate and severe SAD
had a markedly reduced QoL, compared to 4.6% in the
control group.9 Studies suggest that even patients with
SAD who do not have significant comorbid depression or
anxiety are substantially impaired in mental health and
social functioning.10
Studies assessing QoL in SAD after CBT are scarce.
However, the impact of SAD on self-perceived QoL
immediately after treatment8 and at 6-month follow-up
have been investigated.11 Studies suggested that patients
with SAD had very low self-rated QoL scores, which varied
with symptomatic distress and impairment. This research
has also found that socially anxious patients showed
significant improvement in self-perceived QoL immediately
after cognitive-behavioral group therapy (CBGT).8 Such
Correspondence: Irismar Reis de-Oliveira, Departamento de
Neurocieˆncias e Sau´de Mental, Largo do Terreiro de Jesus, s/n6,
Centro Histo´rico, CEP 40026-010, Salvador, BA, Brazil.
E-mail: irismar.oliveira@uol.com.br
Submitted Apr 06 2012, accepted Oct 20 2012.
Revista Brasileira de Psiquiatria. 2013;35:243–247
 2013 Associac¸a˜o Brasileira de Psiquiatria
doi:10.1590/1516-4446-2012-0863
gains were maintained from post-treatment to 6-month
follow-up.11 A more recent study of SAD patients who
received 12 to 20 2-hour CBGT sessions concluded that,
although symptoms of SAD and some aspects of QoL
improved for up to 12 months after CBGT, the social
functioning domain did not change, suggesting the need
for better treatments for this condition.12
The trial-based thought record (TBTR),13 a novel
approach used in trial-based cognitive therapy (TBCT),14
was developed to address negative core beliefs (CBs) in
CBT. In TBTR, the therapist engages the patient in a
simulation of a legal trial, stimulating the activation of
negative CBs and associated negative emotions, with the
aim of reducing their effect with disconfirming evidence.
The repeated use of TBTR may eventually deactivate
negative dysfunctional CBs, as more credible evidence in
support of functional CBs is produced.15
In the present study, we hypothesized that TBTR would
reduce symptoms of social anxiety by restructuring CBs.
The objective was to assess the short- (4-month) and
long-term (12-month) efficacy of TBTR in SAD. Findings
regarding QoL are reported in the present study, while a
detailed description of results involving other clinical
outcomes has been previously published.16
Methods
The method used in this study is described in greater
detail elsewhere,16 but a brief description of the main
methodological aspects is provided below.
Advertisements in local newspapers and interviews
about social anxiety given by the first author to local radio
and television stations were used to recruit the patients.
Only people who met DSM-IV criteria for generalized
SAD were included in the study. All patients were
assessed at an anxiety disorders clinic in a university
teaching hospital.
Forty-seven patients who completed initial assess-
ments were randomized to treatment, with 25 of these
allocated to TBTR and 22 to conventional cognitive
therapy (CCT) (Figure 1). However, differently from the
clinical outcomes described elsewhere,14 the final sample
for QoL analyses in the present study included only the
16 patients in the TBTR group and 14 in the CCT group
who had attended all 12 treatment sessions.
The study was a two-arm randomized trial comparing
TBTR with a set of CCT techniques, which included the
standard dysfunctional thought record (DTR) and the
positive data log (PDL).17 The researcher conducting
randomization was blind to the treatment protocol. After
signing the informed consent form, participants were
assessed with the Mini International Neuropsychiatric
Interview (MINI).18 Participants of any gender or ethnic
group, aged 18 to 70, able to read and write, who fulfilled
DSM-IV criteria for SAD, generalized type were included
in the study. Exclusion criteria comprised major comorbid
Axis I psychiatric disorders (e.g., major depression,
schizophrenia, bipolar disorder), alcohol or substance
use/abuse in the past 6 months, suicide risk, or presently
being in psychotherapy.
Treatment consisted of 10 weekly 1-hour individual
sessions of either TBTR (experimental group) or CCT,
and two 1-hour biweekly sessions in the last 4 weeks.
Sessions 1 to 5 in both treatment conditions involved
psychoeducation about the cognitive model and cognitive
distortions. From session 6 onward, both treatments
focused on restructuring CBs with either the TBTR or
CCT, specifically the standard 7-column DTR and the
PDL. TBTR techniques differed from the CCT techniques
in that (in addition to simulating a legal trial) patients were
actively stimulated to disqualify the evidence that did not
support the negative CBs (e.g., ‘‘I am awkward’’).
Afterwards, by means of a sentence-reversal approach,
the therapist engaged the patients in a second round
exploring the evidence that supported the positive CBs
(e. g., ‘‘I am normal’’). TBTR also differed from the CCT
techniques in that in TBTR the new positive CBs were
uncovered by means of the upward arrow technique.
From sessions 6 through 12, both approaches (TBTR and
CCT) were focused on uncovering and bolstering the new
positive CBs. Although the DTR was not designed by
Beck et al.19 or modified by Greenberger and Padesky20
to change CBs, it is one of the most commonly used
techniques for this purpose. Furthermore, the PDL was
specifically designed to change CBs,17 which is why it
was included in the contrast group.
All the therapists were psychologists and certified
cognitive therapists previously trained in both
approaches. Therapists had attended a 2-year cognitive
therapy specialization course organized by two of the
authors (IRO and VBP). They were invited to participate
in the study because they were among those who had the
best performance during training. The course included
384 h of theory, 60 h of clinical experience with patients
and 86 h of supervision. Also, knowledge and compe-
tence were assessed through a total of 23 monthly written
exams throughout the course. In addition to having
completed the specialization course, all therapists had
at least 1 year of experience in private practice as
certified cognitive therapists at the time the clinical trial
began. All therapists received training together, so that
therapists in both arms (i.e., TBCT and CCT) had
equivalent experience and expertise in both approaches.
Assessment of QoL was performed with the Brazilian
version21 of the Short Form 36 (SF-36),22 a 36-item self-
report questionnaire addressing the following domains:
physical functioning, role-physical, bodily pain, general
health perception, vitality, social functioning, role-
emotional and mental health. The questionnaire was
administered at pre-treatment, post-treatment (4
months), and 12-month follow-up.
All patients who provided at least two SF-36 assess-
ments (baseline and post-treatment) were included in the
analyses (completers). However, a last observed carried
forward (LOCF) intention-to-treat approach was
employed for the 12-month follow-up analyses, so that
analyses included completers at post-treatment and
intention-to-treat (ITT) at follow-up.
A mixed (repeated measures) analysis of variance
(ANOVA) was implemented to evaluate the efficacy of the
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interventions, with the number of assessments (pre-
treatment, post-treatment and follow-up) being computed
as a within-subject factor (time) and treatment modality
(TBCT and CCT) as a between-subjects factor. We also
conducted a one-way analysis of covariance (ANCOVA)
using baseline scores as covariates. Level of significance
was set at .05. Analyses were conducted with the SPSS
17.0 software.
Within-subjects Cohen’s d effect sizes were also
calculated.23 Effect sizes (ESs) of 0-0.32 were consid-
ered small, scores of 0.33-0.55 were considered moder-
ate, while those between 0.56 and 1.2 were interpreted
as large. ESs greater than 1.2 were assumed to be very
large.
Results
A mixed (repeated measures) ANOVA revealed a
significant time effect in the general health, vitality, social
functioning and mental health domains of QoL, and the
results of this analysis are displayed in Table 1. This table
also displays significant treatment effects in the bodily
pain, social functioning, role-emotional, and mental health
domains, with higher scores in the TBTR group. A one-
way ANCOVA, taking pre-treatment values as covariates,
showed that TBTR led to significantly better post-
treatment (bodily pain, social functioning and role-emo-
tional) and follow-up (role-emotional) results than the
CCT techniques. There was also a significant treatment
effect on the role-emotional domain at follow-up, showing
a sustained effect of TBTR relative to CCT.
Table 2 shows Cohen’s d ESs for both TBTR and CCT.
Discussion
The present study shows that both CCT and TBTR, a
novel cognitive behavioral approach,24 improved several
domains of QoL, namely general health, vitality, social
Figure 1 Flow diagram of participants through stages in the randomized trial. CCT = conventional cognitive therapy; TBTR =
trial-based thought record.
Core beliefs and quality of life in social phobia 245
Rev Bras Psiquiatr. 2013;35(3)
functioning, and mental health. As far as we know, this is
the first study comparing QoL measures following a new
CBT approach with standard CBT techniques in SAD.
Moreover, we are aware of no studies comparing the
long-term outcomes of different CBT approaches.
An earlier study12 of SAD patients found modest
improvement in aspects of QoL following treatment,
which were maintained at the 12-month follow-up. The
Cohen’s d ESs seen in the CCT group in the present
study (Table 2) were similar or slightly larger than those
Table 1 Quality of life measures according to the SF-36 (TBTR, n=16; CCT, n=14) at baseline, post-treatment and 12-month
follow-up (mean and SD)
Measures Pre-treatment Post-treatment Follow-up Mixed ANOVA
Physical functioning
TBTR 84.69 (15.44) 88.56 (15.57) 85.62 (16.62) F(1.84, 51.61) = 1.21*
CCT 73.93 (16.55) 82.14 (21.37) 78.21 (19.18) F(1.84, 51.61) = 0.50{
ANCOVA{ F(1, 27) = 0.82 F(1, 27) = 0.05 F(1, 28) = 1.98
1
Role-physical
TBTR 76.56 (32.23) 84.38 (30.10) 75.00 (34.16) F(1.88, 52.69) = 0.06*
CCT 66.07 (38.74) 82.14 (31.67) 71.43 (33.77) F(1.88, 52.69) = 0.20{
ANCOVA{ F(1, 27) = 0.00 F(1, 27) = 0.00 F(1, 28) = 0.36
1
Bodily pain
TBTR 78.19 (21.83) 87.06 (15.83) 83.19 (15.31) F(1.82, 51.10) = 1.27*
CCT 67.57 (26.51) 70.14 (21.01) 67.93 (22.76) F(1.82, 51.10) = 0.41{
ANCOVA{ F(1, 27) = 4.45
I
F(1, 27) = 3.18 F(1, 28) = 5.06
1I
General health
TBTR 67.97 (15.18) 77.44 (17.08) 75.75 (18.68) F(1.98, 55.48) = 8.21*
"
CCT 56.79 (19.61) 66.71 (21.48) 64.50 (21.60) F(1.98, 55.48) = 0.00{
ANCOVA{ F(1, 27) = 0.14 F(1, 27) = 0.06 F(1, 28) = 3.13
1
Vitality
TBTR 44.37 (19.22) 61.56 (19.64) 57.50 (20.66) F(1.71, 48.01) = 8.87*
"
CCT 41.43 (16.81) 54.29 (16.85) 51.07 (21.32) F(1.71, 48.01) = 0.20{
ANCOVA{ F(1, 27) = 0.97 F(1, 27) = 0.49 F(1, 28) = 0.87
1
Social functioning
TBTR 50.00 (27.00) 84.19 (21.24) 69.38 (23.67) F(1.89, 52.93) = 6.21*
I
CCT 44.64 (23.37) 61.64 (21.07) 52.68 (22.02) F(1.89, 52.93) = 1.06{
ANCOVA{ F(1, 27) = 8.34
"
F(1, 27) = 3.47 F(1, 28) = 5.57
1I
Role-emotional
TBTR 45.79 (36.26) 77.09 (29.12) 70.81 (34.16) F(1.63, 45.55) = 1.69*
CCT 40.46 (37.39) 49.99 (44.81) 36.89 (35.90) F(1.63, 45.55) = 3.01{
ANCOVA{ F(1, 27) = 4.26
I
F(1, 27) = 6.61
I
F(1, 28) = 4.27
1I
Mental health
TBTR 55.25 (14.77) 71.62 (15.39) 66.25 (18.82) F(1.56, 43.62) = 7.53*
"
CCT 45.71 (17.52) 59.71 (15.33) 54.86 (19.31) F(1.56, 43.62) = 0.06{
ANCOVA{ F(1, 27) = 1.93 F(1, 27) = 1.12 F(1, 28) = 4.53
1I
ANCOVA = one-way analysis of covariance; ANOVA = analysis of variance; CCT = conventional cognitive therapy; ES = Cohen’s d effect
size; SD = standard deviation; SF-36 = Short Form 36; TBTR = trial-based thought record.
* Overall time effect.
{ Interaction (time x treatment) effect.
{ ANCOVA with pretreatment assessments as covariates.
1 Treatment (group) effect.
I p f 0.05; " p f 0.01.
Table 2 Cohen’s d effect sizes found in this study and in Watanabe et al.21
SF-36 domains CCT, post-/F-U TBCT, post-/F-U Watanabe et al., post-/F-U
Physical functioning 0.43/0.24 0.25/0.06 0.10/0.15
Role-physical 0.45/0.15 0.25/0.05 0.06/0.39
Bodily pain 0.11/0.01 0.47*/0.27 0.24/0.12
General health 0.48/0.37 0.59/0.46 0.28/0.44
Vitality 0.76/0.50 0.88/0.66 0.51/0.29
Social functioning 0.76/0.35 1.41{/0.76 0.30/0.28
Role-emotional 0.23/-0.10 0.95*/0.71* 0.07/0.08
Mental health 0.85/0.50 1.09/0.65 0.39/0.32
CCT = conventional cognitive therapy; TBTR = trial-based thought record; post- = post-treatment; F-U = follow-up.
* p f 0.05; p f 0.01.
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found in the aforementioned study.12 However, TBTR had
large to very large ESs at post-treatment in the mental
health (ES = 1.09) and social functioning (ES = 1.41)
domains, as well as large ESs in the social functioning
domains (ES = 0.76) at follow-up, and these results were
not accomplished neither in the CCT contrast group of
our study nor in that study.12 A possible explanation for
this finding is that TBTR had a more significant effect on
fear of negative evaluation (FNE) scores than CCT
techniques, as shown in a previous publication of this
study.16 The one-way ANCOVA showed a significant
treatment effect (F[1, 33] = 5.47; p = 0.03) at mid-
treatment and at post-treatment, with participants in the
TBTR group scoring lower on FNE assessments than
participants in the CCT group.
Clearly, results from this study should be interpreted in
light of its limitations. Firstly, the sample size was small.
Secondly, patients were recruited by means of advertise-
ments and interviews on radio and television, which may
mean this sample is not representative of the treatment-
seeking SAD population, even though all participants
fulfilled DSM-IV criteria for generalized SAD. Thirdly, all
patients received the same intervention in the initial
phase of the study (i.e., first 5 sessions), so the
comparison is based on a short duration of treatment
(weeks 6 to 12). Nevertheless, even with this short
duration of treatment, significant differences emerged on
several SF-36 domains. A final limitation was that
comparison was performed with a contrast group rather
than a control group. The latter would have added value
to this study.
In summary, this pattern of findings allows us to
conclude that TBTR is significantly more effective than
CCT, specifically the standard 7-column DTR and the
PDL, in improving several domains of QoL in the short-
(namely bodily pain, social functioning and role-emo-
tional) and long-term (namely role-emotional). These
results suggest that it would be valuable to investigate
the efficacy of TBTR, as well as the broader approach,
TBCT,24 in a larger sample of patients with SAD, as well
as in patients with other psychiatric disorders character-
ized by dysfunctional CBs.25
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